US Flu Vaccine Market Outlook 2024

About This Presentation
Title:

US Flu Vaccine Market Outlook 2024

Description:

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine. Buy Now: Long–term Growth Projection and Development: • Sanofi to Acquire Protein Sciences Corporation • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024 • Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season • It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024 • BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine – PowerPoint PPT presentation

Number of Views:9

less

Transcript and Presenter's Notes

Title: US Flu Vaccine Market Outlook 2024


1
DPI RESEARCH
Leading Market Research Company

Sales_at_dpiresearch.com www.dpiresearch.com
2
United States Flu Vaccine Market
Report Title
Flu Vaccine Market Outlook 2024 United
States Opportunity and Demand Analysis, Market
Forecast 2017-2024
Title Link http//www.dpiresearch.com/report-det
ails.php?P_ID109
3
United States Flu Vaccine Market
Publish Date 21st August 2017 No. of Pages
120 Geography Coverage United States Price
for Single User Licence USD 1150 Price for
Global User Licence USD 1700 Delivery Time
Within 24 hours
4
United States Flu Vaccine Market
Report Coverage 1.  Executive Summary 2.
Market Overview United States Flu Vaccine Market
(2010 -  2024)    3. United States Number of
Persons Vaccinated with Flu Vaccine (2010
2024)  4. Key Drivers and Inhibitors of the
United States Flu Vaccine Market 5. United
States Flu Vaccine Production, Price,
Consumption, Supply, Distribution, Demand
and Specification         
5
United States Flu Vaccine Market
Report Coverage Continues 6. United States Flu
Vaccine Market Reimbursement Regulatory
System 7. Market Dynamics Mergers,
Acquisitions, Key Agreements
Collaborations 8. Flu Vaccine Promising
Vaccine in Clinical Development 9. Flu Vaccine
Clinical Trial Insights by Phase, Company
Country 10. Key Companies Analysis
Write a Comment
User Comments (0)